NDAORALTABLET
Approved
May 2021
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
unclear; however, its efficacy in the treatment of schizophrenia or bipolar I disorder could be mediated through a combination of dopamine and serotonin type 2 (5HT 2 ) antagonism. The mechanism of action of samidorphan could be mediated through opioid receptor antagonism.
Pharmacologic Class:
Atypical Antipsychotic
Indications (1)
Loss of Exclusivity
LOE Date
Nov 12, 2041
191 months away
Patent Expiry
Nov 12, 2041
Exclusivity Expiry
May 28, 2026
Company
Alkermes
DUBLIN 4, Ireland